The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Asthma Drugs Market Research Report 2024
Synopsis
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
The global Asthma Drugs market was valued at US$ 219.5 million in 2023 and is anticipated to reach US$ 293.5 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.
This report aims to provide a comprehensive presentation of the global market for Asthma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Drugs.
Report Scope
The Asthma Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
Segment by Type
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma
Segment by Application
Allergic Asthma
Non-Allergic Asthma
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
The global Asthma Drugs market was valued at US$ 219.5 million in 2023 and is anticipated to reach US$ 293.5 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.
This report aims to provide a comprehensive presentation of the global market for Asthma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Drugs.
Report Scope
The Asthma Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
Segment by Type
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma
Segment by Application
Allergic Asthma
Non-Allergic Asthma
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Asthma Drugs Market Overview
1.1 Product Overview and Scope of Asthma Drugs
1.2 Asthma Drugs Segment by Type
1.2.1 Global Asthma Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Quick-relief Medications (Rescue Medications)
1.2.3 Medications for Allergy-induced Asthma
1.3 Asthma Drugs Segment by Application
1.3.1 Global Asthma Drugs Market Value by Application: (2024-2030)
1.3.2 Allergic Asthma
1.3.3 Non-Allergic Asthma
1.4 Global Asthma Drugs Market Size Estimates and Forecasts
1.4.1 Global Asthma Drugs Revenue 2019-2030
1.4.2 Global Asthma Drugs Sales 2019-2030
1.4.3 Global Asthma Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma Drugs Market Competition by Manufacturers
2.1 Global Asthma Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Asthma Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Drugs, Product Type & Application
2.7 Asthma Drugs Market Competitive Situation and Trends
2.7.1 Asthma Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma Drugs Players Market Share by Revenue
2.7.3 Global Asthma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma Drugs Retrospective Market Scenario by Region
3.1 Global Asthma Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma Drugs Global Asthma Drugs Sales by Region: 2019-2030
3.2.1 Global Asthma Drugs Sales by Region: 2019-2024
3.2.2 Global Asthma Drugs Sales by Region: 2025-2030
3.3 Global Asthma Drugs Global Asthma Drugs Revenue by Region: 2019-2030
3.3.1 Global Asthma Drugs Revenue by Region: 2019-2024
3.3.2 Global Asthma Drugs Revenue by Region: 2025-2030
3.4 North America Asthma Drugs Market Facts & Figures by Country
3.4.1 North America Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma Drugs Sales by Country (2019-2030)
3.4.3 North America Asthma Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma Drugs Market Facts & Figures by Country
3.5.1 Europe Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma Drugs Sales by Country (2019-2030)
3.5.3 Europe Asthma Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma Drugs Market Facts & Figures by Country
3.7.1 Latin America Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma Drugs Sales by Country (2019-2030)
3.7.3 Latin America Asthma Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma Drugs Sales by Type (2019-2030)
4.1.1 Global Asthma Drugs Sales by Type (2019-2024)
4.1.2 Global Asthma Drugs Sales by Type (2025-2030)
4.1.3 Global Asthma Drugs Sales Market Share by Type (2019-2030)
4.2 Global Asthma Drugs Revenue by Type (2019-2030)
4.2.1 Global Asthma Drugs Revenue by Type (2019-2024)
4.2.2 Global Asthma Drugs Revenue by Type (2025-2030)
4.2.3 Global Asthma Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma Drugs Sales by Application (2019-2030)
5.1.1 Global Asthma Drugs Sales by Application (2019-2024)
5.1.2 Global Asthma Drugs Sales by Application (2025-2030)
5.1.3 Global Asthma Drugs Sales Market Share by Application (2019-2030)
5.2 Global Asthma Drugs Revenue by Application (2019-2030)
5.2.1 Global Asthma Drugs Revenue by Application (2019-2024)
5.2.2 Global Asthma Drugs Revenue by Application (2025-2030)
5.2.3 Global Asthma Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Asthma Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Asthma Drugs Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Asthma Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Asthma Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Ingelheim Asthma Drugs Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Asthma Drugs Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Asthma Drugs Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Corporation Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Pharmaceutical Asthma Drugs Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 Vectura Group
6.9.1 Vectura Group Corporation Information
6.9.2 Vectura Group Description and Business Overview
6.9.3 Vectura Group Asthma Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vectura Group Asthma Drugs Product Portfolio
6.9.5 Vectura Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Drugs Industry Chain Analysis
7.2 Asthma Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Drugs Production Mode & Process
7.4 Asthma Drugs Sales and Marketing
7.4.1 Asthma Drugs Sales Channels
7.4.2 Asthma Drugs Distributors
7.5 Asthma Drugs Customers
8 Asthma Drugs Market Dynamics
8.1 Asthma Drugs Industry Trends
8.2 Asthma Drugs Market Drivers
8.3 Asthma Drugs Market Challenges
8.4 Asthma Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
